Hyaluronidase Market Size

Hyaluronidase Market size is expected to reach USD 12 billion by the end of 2036, witnessing around CAGR 9% during the forecast period i.e., 2023 – 2036. In the year 2023, the industry size of hyaluronidase was around 1 billion. The growth of this market can be attributed to the account of the increasing prevalence of chronic diseases worldwide. Chronic diseases such as cancer and diabetes can lead to the accumulation of hyaluronic acid in tissues. This can cause a variety of problems, such as pain, inflammation, and swelling. Hyaluronidase can be used to break down hyaluronic acid and retrieve these symptoms. Every year 41 million people die out of chronic disease which is 74% of world’s population. 

Furthermore, increasing technological advancement in the development of hyaluronidase power injections has made them more effective and safer. For instance, the development of recombinant hyaluronidase has reduced the risk of allergic reactions.